A Study of LIVTENCITY (Maribavir) in Adults With Cytomegalovirus (CMV) Infection After Transplantation in South Korea

NCT06555432 · clinicaltrials.gov ↗

RECRUITING

Status

168

Enrollment

INDUSTRY

Sponsor class

Conditions

Cytomegalovirus (CMV)

Interventions

DRUG: LIVTENCITY

Sponsor

Takeda